TELESTA THERAPEUTICS INC T.TST

Partnership coming $ 640 million to $740 million.

[Jasl]

Will you guys be happy with $3 plus a share or will you hold out for the true value of $11-$13 a share. ? Just curious cause it's coming soon three weeks there will be multiple offers for our little wonder therapy. 
Cheers
JASL

[simouuun]

Jasl, your words a very nice to read... sweet dreaming guaranteed. But why in 3 weeks and how do you work out 11-13$ per share for you? Can you explain your calculation?

[Jasl]

The very minute the decision came down gave us footing. Takes three weeks on average if you have a team of pharmaceutical speculators to put a deal together. And I suspect more than one company. I maybe wrong.  But if I was looking for acquisitions this would be a bit of a gem. No ? Do math on per dose per patient. It's roughly I mean roughly $76000.00 per patient and that's low

[DamnYankees]

Forget $3, let alone $11, at the moment there is nobody willing to pay 45 cents Canadian. I have a hunch that last Friday's news was known for a while especially by those participating at 34 cents. And trading below Friday's meagre close after confirmation of a priority review has got to be more than a bit embarassing for the company. I don't see takeout offers beyond $1.50 canadian

[Jasl]

Fair enough. My opinion as I stated. Take the $1.50!  Cheers  JASL

[DamnYankees]

Correct, it is just an opinion and yes I will take the $1.50, as would everybody here as the depleting 44 cent bids indicate

[conspiTheory]

-French Canada company like Valeant -small target population to the point that FDA refused to give TST orphan drug designation -regulatory risk, yeah right lets continue to use BCG but just between shortage -emerging competition like may be 2020 if they pass P3 and FDA. funny how the companies that are only in P1/2 are more valued  and less risky than a P3 company that FDA is aware of. So

[Ghanam]

Good points, thanks for posting.

[simouuun]

Sorry, but what is IMVYON?

[Ghanam]

It's a trademark of Telesta, registered not long ago... IMVYON

[simouuun]

Thanks, so it is the trade name of MCNA.. But what does this concern with Roche's IMVIGOR? Besides thes simliar name...? I don't get it.

[Ghanam]

Roche's is a multi billion $ concern which develops a bladder cancer drug called IMVIGOR (Phase II IMHO, Phase III enrolling, years apart, correct me if i'm wrong). Telesta has a Phase III bladder cancer drug with a registered trademark called IMVYON, shortly before marketlaunch (if all goes well, ofcourse). If you're in Roche's management, would you mind? I would&excl